Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584010 | Seminars in Arthritis and Rheumatism | 2016 | 28 Pages |
Abstract
Anti-Jo1 ASS is a heterogeneous syndrome. ILD in ASS under immunosuppressive therapy is mainly a non-progressive disease. Dyspnea at ILD onset and a steady FVC decrease over time were related to a poorer respiratory prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ernesto MD, PhD, Josep MarÃa MD, PhD, Anne MD, PhD, Francisco José MD, Manuel MD, PhD, Guadalupe MD, Iñigo MD, PhD, Mónica MD, PhD, Luis MD, PhD, Albert MD, PhD,